The fenofibrate micronized powders were prepared using lactose and MCC as the main expicients for preparation of fenofibrate tablets.

以糖和微晶纤维素作为主要辅料制备非诺贝特的微化物,并以此制备片剂,辅以预胶化淀调节片剂的溶出度。

Objective To investigate the effects of micronized fenofibrate on low density lipoprotein (LDL) subfraction profiles in type IV hyperlipidemic subjects.

目的观察微粒化非诺贝特对IV型高脂血症患者血清低密度脂蛋白（LDL）亚组布的作用。

Similarly, fenofibrate and the combination (but not simvastatin) significantly increased the percentage of buoyant LDL cholesterol constituting total LDL cholesterol.

类似的，非诺贝特和联合治疗显著升高有浮力的LDL在总LDL中的比例。